Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Redx confirms Jounce deal lapses, Tirupati seals deal

Mon, 03rd Apr 2023 18:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Confirms that proposed all-share merger with Jounce Therapeutics has formally lapsed. Follows decision by Jounce to agree an alternative merger proposal with Concentra Biosciences, announced on March 27. Chief Executive Lisa Anson calls decision "disappointing," but notes Redx is "poised to achieve significant value inflection points from both clinical stage assets and development candidates in the next 12 months." Continues to evaluate relevant strategic and financial opportunities.

----------

Great Eastern Energy Corp Ltd - Asansol, India-based coal bed methane company - Confirms the last day of trading of the global depository receipts will be April 21. Following cancellation, GDRs will become unlisted GDRs. Apart from being unlisted, GDRs will continue to have the same structure as present.

----------

Litigation Capital Management Ltd - asset manager specialising in dispute financing solutions - Announces the realisation and cash receipt of an investment which forms part of LCM's Fund I portfolio. In December, High Court judged in favour LCM's funded party, the liquidator of CGL Realisations Ltd, formerly known as Comet Group Ltd. Under the judgement around GBP110 million was paid into court by the respondent who is appealing the ruling. In the interim, the liquidator procured a judgment protection insurance policy. Subsequently, an application was made for payment of sufficient monies to pay LCM's entitlements under the litigation funding agreement as well as the cost of defending the appeal. This enabled the liquidator to finalise its obligations to LCM, bringing about a conclusion to this investment. CEO Patrick Moloney says: "The resolution provides a further example of how the use of managed third party investment funds leverages the return to LCM's balance sheet and its equity investors."

----------

Kefi Gold and Copper PLC - Gold exploration and development company, focused on Ethiopia and Saudi Arabia - Reports maiden mineral resource estimate at the Al Godeyer Project, which forms part of the Hawiah Complex, part of Kefi's Saudi Arabian joint-venture Gold and Minerals Company Ltd. Says MRE of 1.4 million tonnes at 0.6% copper, 0.54% zinc, 1.4 grams per tonne of gold and 6.6 grams per tonne of silver potentially complements the inferred resources reported at the nearby Hawiah deposit of 11.1 million tonnes. This reaffirms the potential for an initial open-pit mining operation at Hawiah. Drilling planned to commence in the second quarter aimed at converting unclassified areas of the deposit to the Inferred category and to further test the strike extent of the orebody. Concurrent drilling planned at Hawiah will focus on upgrading and further expanding its total resources. Executive Chairman Harry Anagnostaras-Adams says: "Feedback from the early metallurgical test work is particularly exciting and demonstrates the amenability of Al Godeyer to provide additional open pit feed material to the proposed Hawiah Complex."

----------

Great Southern Copper PLC - copper-gold exploration company focused on Chile - Reports mapping identifies multiple mineralised vein-breccia structures at the Victoria prospect. Notes rock chip assay grades up to 6.9% copper and 1.85 grams per tonne of gold in the prospect. Sees potential for additional vein-breccia structures under shallow cover. Adds planning is now underway for the next phase of exploration at Victoria which is designed to identify targets for prospect-scale reconnaissance drilling. This work will include further detailed mapping and sampling complimented with trenching and magnetic and induced polarization geophysical surveys.

----------

San Leon Energy PLC - oil and gas production, development and exploration company focused on Nigeria - Updates on proposed transactions, refinancing and ELI operations. Reports longstop dates relation to proposed transactions with Midwestern Oil & Gas Co Ltd have been extended to June 30. This relates to the new Eroton debt facilities, the Sahara OML 18 acquisition agreement, the MLPL reorganisation agreement and the ELI reorganisation agreement. Continues to believe that the proposed transactions will be transformational.

----------

Tirupati Graphite PLC - London and Mumbai-based specialist graphite and graphene producer with operations in Madagascar and India - Completes acquisition of Suni Resources SA, the Mozambique incorporated subsidiary of ASX listed Battery Minerals Ltd. Deal was announced in September 2022.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Updates on its capital structure and funding. Expects the group will need to raise further equity finance, or potentially new loan finance, in the coming months. Based on success of previous fund raising and the current performance of the business, continues to have a reasonable expectation of raising sufficient additional equity capital or new loan finance. Highlights renewed interest for Fruitflow. Committed to buy more than GBP550,000 of inventory from DSM. In direct contact with more than 50 actual and prospective Fruitflow customers and is seeking to ascertain the likely demand for the next 12 months and beyond, with particular regard to the best before dates of DSM's remaining inventory. In talks with DSM regarding extending initial inventory handover period. In talks with third party who may be able to hold inventory on a consignment basis.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
13 Dec 2022 15:53

UK earnings, trading statements calendar - next 7 days

Wednesday 14 December 
Cohort PLCHalf Year Results
CyanConnode Holdings PLCHalf Year Results
Foresight Sustainable Forestry Co PLCFull Year Results
IntegraFin Holdings PLCFull Year Results
SThree PLCTrading Statement
Tui AGFull Year Results
Watches of Switzerland Group PLCHalf Year Results
Thursday 15 December 
Biffa PLCHalf Year Results
C4X Discovery Holdings PLCFull Year Results
Currys PLCHalf Year Results
Libertine Holdings PLCHalf Year Results
RWS Holdings PLCFull Year Results
Serco Group PLCTrading Statement
Friday 16 December 
Gore Street Energy Storage Fund PLCHalf Year Results
Hollywood Bowl Group PLCFull Year Results
Monday 19 December 
Thruvision Group PLCHalf Year Results
Tuesday 20 December 
Jersey Electricity PLCFull Year Results
Petrofac LtdTrading Statement
Redx Pharma PLCFull Year Results
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
11 Nov 2022 15:24

TRADING UPDATES: De La Rue defends chair; Resolute Mining fundraise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
11 Oct 2022 14:51

TRADING UPDATES: Scirocco repays loan; Vp says rail strikes slow works

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Oct 2022 22:06

TRADING UPDATES: Blencowe Resources sees potential interest from China

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Aug 2022 13:58

Redx Pharma staff sell 1.5 million shares via accelerated bookbuild

(Alliance News) - Redx Pharma PLC on Friday confirmed that Chief Scientific Officer Richard Armer and other current and former employees have sold a total of 1.5 million shares at 59 pence each via an accelerated bookbuild.

Read more
3 Aug 2022 17:57

IN BRIEF: Redx Pharma employees to sell at least GBP605,120 in shares

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Chief Scientific Officer Richard Armer and other current and former employees look to sell 1.5 million shares at a minimum price of 59 pence each via an accelerated bookbuild, which is 11% discount to Tuesday's closing price of 66.50p.

Read more
27 Jun 2022 16:01

IN BRIEF: Redx Pharma reports "encouraging" fibrosis treatment data

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Notes encouraging preclinical data for the potential of its Porcupine and ROCK inhibitors to tackle cancer-associated fibrosis. Further data supported the ROCK inhibitor as a potential treatment for fibrostenotic Crohn's disease.

Read more
23 Jun 2022 11:29

IN BRIEF: Redx Pharma narrows half-year loss as pipeline progresses

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - In the half year ended March 31, pretax loss narrows to GBP9.7 million from GBP12.7 million year-on-year. Revenue multiplies to GBP8.4 million from GBP2.1million. Reports strong progress across its pipeline, especially its lead oncology asset RXC004 moving into phase II clinical trials, and its lead fibrosis asset, RXC007, reporting "encouraging" phase I safety data. Says its Rock inhibitor RXC008 has the potential to become a first-in-class treatment for fibrostenotic Crohn's disease, and is likely to be ready to enter the clinic by the end of next year.

Read more
16 Jun 2022 16:05

UK earnings, trading statements calendar - next 7 days

Friday 17 June 
Tesco PLCQ1 Results
Monday 20 June 
Associated British Foods PLCQ3 Results
SysGroup PLCFull Year Results
SThree PLCTrading Statement
Tuesday 21 June 
DS Smith PLCFull Year Results
Gear4Music PLCFull Year Results
Monks Investment Trust PLCFull Year Results
Record PLCFull Year Results
Safestore Holdings PLCHalf Year Results
Telecom Plus PLCFull Year Results
Wednesday 22 June 
Berkeley Group Holdings PLCFull Year Results
Liontrust Asset Management PLCFull Year Results
Micro Focus International PLCHalf Year Results
Thursday 23 June 
DeepVerge PLCFull Year Results
First Property Group PLCFull Year Results
Manolete Partners PLCFull Year Results
Naked Wines PLCFull Year Results
Oxford Metrics PLCHalf Year Results
Redx Pharma PLCHalf Year Results
Serco Group PLCTrading Statement
Volex PLCFull Year Results
XPS Pensions Group PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
15 Jun 2022 10:24

Redx Pharma rises on FDA clearance for solid tumour treatment JZP815

(Alliance News) - Redx Pharma PLC on Wednesday said the US Food & Drug Administration has cleared the investigational new drug application for JZP815, a pan-RAF inhibitor for the treatment of solid tumours and haematological malignancies.

Read more
19 May 2022 18:55

TRADING UPDATES: Knights tips revenue hike; Gym Group eyes growth

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 May 2022 19:37

IN BRIEF: Redx Pharma to raise GBP30 million to fund pipelines

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Proposes to raise GBP30 million through a placing to institutional investors of shares at a price of 59 pence each.

Read more
8 Apr 2022 19:41

IN BRIEF: Redx Pharma notes "encouraging" RXC004 data in cancer

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Notes "encouraging" preclincal data for RXC004 as a targeted therapy for Wnt-ligand driven cancer.

Read more
5 Apr 2022 21:39

TRADING UPDATES: Alpha FX restarts relationship; Atalaya resources up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
30 Mar 2022 11:05

IN BRIEF: Redx Pharma to start new Crohn's disease study in late 2023

Redx Pharma PLC - Cheshire-based cancer and fibrosis drug developer - Announces end of 2023 as start of phase 1 studies for its Crohn's disease clinical development candidate RXC008. The inhibitor is designed to act exclusively in the gastrointestinal tract at the site of fibrosis in Crohn's disease patients. Up to 50% of patients with Crohn's disease can develop significant fibrosis, the company says, citing a 2013 study published by the National Center for Biotechnology Information based in Bethesda, Maryland, United States.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.